Praxis Precision Medicines (PRAX) Shares Outstanding (Weighted Average) (2019 - 2026)

Praxis Precision Medicines' Shares Outstanding (Weighted Average) history runs 8 years deep, the most recent figure standing at $704225.0 for Q1 2026.

• In Q1 2026, Shares Outstanding (Weighted Average) fell 96.66% year-over-year to $704225.0; the TTM figure through Mar 2026 stood at $704225.0 (down 96.66% YoY), while the FY2025 annual figure was $704225.0, down 96.07% from the prior year.
• Shares Outstanding (Weighted Average) was $704225.0 for Q1 2026 at Praxis Precision Medicines, roughly flat from $704225.0 in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $45.8 million in Q3 2022 to a low of $704225.0 in Q2 2025.
• Historically, Shares Outstanding (Weighted Average) has averaged $14.0 million across 5 years, with a median of $6.6 million in 2023.
• The sharpest annual moves came in 2024 and 2026: Shares Outstanding (Weighted Average) soared 292.76% in 2024, then plunged 96.66% in 2026.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $3.1 million in 2022, then surged by 114.58% to $6.6 million in 2023, then surged by 171.55% to $17.9 million in 2024, then plunged by 96.07% to $704225.0 in 2025, then changed by 0.0% to $704225.0 in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $704225.0 (Q1 2026), $704225.0 (Q4 2025), and $704225.0 (Q3 2025), per Business Quant data.